Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01614262 · ClinicalTrials.gov registry record · NA
Examining The Role of CGM in T2DM
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT01614262 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 35 participants.
The verdict
NCT01614262, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
Continuous glucose monitoring (CGM) technology has advanced the treatment of people with diabetes, however to date this technology had been primarily limited to use in patients treated with insulin. CGM is a powerful tool that has the potential to enhance the care of patients treated with agents other than insulin; however this has not been tested. The purpose of this study is to determine whether improved glycemic control can be achieved through the use of intensive, periodic CGM monitoring in patients with T2DM treated with oral anti-hyperglycemic drugs (OADs). The data gathered from this pilot study will be utilized to determine if a larger, clinical effectiveness study to assess use of CGM to improve clinical outcomes in patients with T2DM treated with OADs is warranted.
Interventions
- OTHER Continuous Glucose Monitoring with treatment algorithm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01614262
The ClinicalTrials.gov registry entry for NCT01614262 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Continuous Glucose Monitoring with treatment algorithm is the first listed.
NCT01614262 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01614262 about?
NCT01614262 is a clinical study titled "Examining The Role of CGM in T2DM". Continuous glucose monitoring (CGM) technology has advanced the treatment of people with diabetes, however to date this technology had been primarily limited to use in patients treated with insulin. CGM is a powerful tool that has the potential to enhance the care of patients treated with agents oth...
What is the current status of trial NCT01614262?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2012-06. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01614262?
The interventions under investigation include: Continuous Glucose Monitoring with treatment algorithm (OTHER).
Who is sponsoring clinical trial NCT01614262?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.